Adaptive resistance to cefiderocol in carbapenem-resistant Acinetobacter baumannii (CRAB): microbiological and clinical issues

Objectives: Determining the best available therapy for carbapenem-resistant Acinetobacter baumannii (CRAB) infections is a challenge. Cefiderocol is an attractive alternative drug effective against many resistance mechanisms in Gram-negative bacteria. However, its place in the treatment of Acinetoba...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Heliyon
المؤلفون الرئيسيون:	Anissa Desmoulin, Loïk Sababadichetty, Laure Kamus, Marion Daniel, Lucie Feletti, Nicolas Allou, Anaïs Potron, Anne-Gaëlle Leroy, Marie-Christine Jaffar-Bandjee, Olivier Belmonte, Thomas Garrigos, Guillaume Miltgen
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Elsevier 2024-05-01
الموضوعات:	Cefiderocol Adaptive resistance Acinetobacter baumannii Therapeutic decision NDM/OXA carbapenemases
الوصول للمادة أونلاين:	http://www.sciencedirect.com/science/article/pii/S2405844024063965